This page has not been authorized, sponsored, or otherwise approved or endorsed by the companies represented herein. Each of the company logos represented herein are trademarks of Microsoft Corporation; Dow Jones & Company; Nasdaq, Inc.; Forbes Media, LLC; Investor's Business Daily, Inc.; and Morningstar, Inc.
Copyright 2024 Zacks Investment Research | 10 S Riverside Plaza Suite #1600 | Chicago, IL 60606
At the center of everything we do is a strong commitment to independent research and sharing its profitable discoveries with investors. This dedication to giving investors a trading advantage led to the creation of our proven Zacks Rank stock-rating system. Since 1988 it has more than doubled the S&P 500 with an average gain of +24.03% per year. These returns cover a period from January 1, 1988 through July 1, 2024. Zacks Rank stock-rating system returns are computed monthly based on the beginning of the month and end of the month Zacks Rank stock prices plus any dividends received during that particular month. A simple, equally-weighted average return of all Zacks Rank stocks is calculated to determine the monthly return. The monthly returns are then compounded to arrive at the annual return. Only Zacks Rank stocks included in Zacks hypothetical portfolios at the beginning of each month are included in the return calculations. Zacks Ranks stocks can, and often do, change throughout the month. Certain Zacks Rank stocks for which no month-end price was available, pricing information was not collected, or for certain other reasons have been excluded from these return calculations. Zacks may license the Zacks Mutual Fund rating provided herein to third parties, including but not limited to the issuer.
Visit Performance Disclosure for information about the performance numbers displayed above.
Visit www.zacksdata.com to get our data and content for your mobile app or website.
Real time prices by BATS. Delayed quotes by Sungard.
NYSE and AMEX data is at least 20 minutes delayed. NASDAQ data is at least 15 minutes delayed.
This site is protected by reCAPTCHA and the Google Privacy Policy, DMCA Policy and Terms of Service apply.
View All Zacks #1 Ranked Stocks
Zacks News
Reinsurance Group (RGA) Q1 Earnings Miss, Revenues Beat
by Zacks Equity Research
Reinsurance Group (RGA) Q1 results reflect adverse impact of significant level of COVID-19 mortality claims.
Manulife (MFC) Q1 Earnings Beat on Solid Segment Results
by Zacks Equity Research
Manulife (MFC) Q1 results reflect favorable impact of markets on seed money investments in new segregated and mutual funds higher new business gains in Asia and the United States.
Lincoln National (LNC) Q1 Earnings Beat, Revenues Up Y/Y
by Zacks Equity Research
Lincoln National's (LNC) first-quarter results highlight growing revenues attributable to well-performing segments, partly offset by the adverse impact of the COVID-19 pandemic.
Lincoln National (LNC) to Post Q1 Results: What's in Store?
by Zacks Equity Research
Lincoln National's (LNC) first-quarter results are likely to benefit from higher account values and cost-cutting initiatives, partly offset by elevated pandemic-related claims.
Should You Buy Manulife (MFC) Ahead of Earnings?
by Zacks Equity Research
Manulife (MFC) is seeing favorable earnings estimate revision activity and has a positive Zacks Earnings ESP heading into earnings season.
What's in the Offing for Assurant (AIZ) in Q1 Earnings?
by Zacks Equity Research
Assurant's (AIZ) first-quarter performance is likely to have been impacted by mobile subscriber growth, lower expenses, and growth in specialty property businesses.
Why the Earnings Surprise Streak Could Continue for Manulife (MFC)
by Zacks Equity Research
Manulife (MFC) has an impressive earnings surprise history and currently possesses the right combination of the two key ingredients for a likely beat in its next quarterly report.
What's in Store for Synchrony Financial's (SYF) Q1 Earnings?
by Zacks Equity Research
Synchrony Financial's (SYF) Q1 earnings are expected to have gained from lower costs, partly offset by weak interest and fees on loans.
6 Insurance Stocks Poised to Surpass Q1 Earnings Estimates
by Srijita Guha
Better pricing, higher underlying underwriting gain, improved combined ratio, exposure growth, redesigning of products and sturdy capital position are expected to help the insurance industry players.
Discover Financial's (DFS) Q1 Earnings Beat, Improve Y/Y
by Zacks Equity Research
Discover Financial's (DFS) first-quarter results reflect better revenues and a solid performance by its Direct Banking business.
Looking for a Fast-paced Momentum Stock at a Bargain? Consider Manulife (MFC)
by Zacks Equity Research
If you are looking for stocks that have gained strong momentum recently but are still trading at reasonable prices, Manulife (MFC) could be a great choice. It is one of the several stocks that passed through our 'Fast-Paced Momentum at a Bargain' screen.
6 Insurers Set to Outperform Estimates This Earnings Season
by Tanuka De
Better pricing, exposure growth, redesigning of products and sturdy capital are expected to help Allstate, Cincinnati Financial, Manulife, Primerica, Cigna, Unum Group outperform Q1 earnings estimates.
Manulife (MFC) to Gain From Solid Asia and WAM Businesses
by Zacks Equity Research
Manulife (MFC) is poised to grow given its solid in-force business growth, disciplined expense management and prudent capital deployment.
Manulife (MFC) Up 10.5% Since Last Earnings Report: Can It Continue?
by Zacks Equity Research
Manulife (MFC) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.
Manulife (MFC) Up 86% in a Year: Will the Rally Continue?
by Zacks Equity Research
Strong Asia business, expanding wealth and asset management business and solid capital position are likely to drive Manulife Financial (MFC).
Why Manulife Financial (MFC) is a Top Dividend Stock for Your Portfolio
by Zacks Equity Research
Dividends are one of the best benefits to being a shareholder, but finding a great dividend stock is no easy task. Does Manulife Financial (MFC) have what it takes? Let's find out.
Manulife (MFC) Q4 Earnings Flat Y/Y, Asia Business Strong
by Zacks Equity Research
Manulife (MFC) Q4 results reflect in-force business growth in Asia and the U.S., higher average AUMA in Global Wealth and Asset Management and lower expenses offset by lower investment income in Corporate and Other.
Insurance Stocks' Q4 Earnings Due on Feb 10: CINF, MFC & More
by Tanuka De
Better pricing, strong retention, new business, favorable renewals, reinsurance agreements are likely to benefit Cincinnati Financial (CINF), Manulife (MFC), Sun Life (SLF), GoHealth (GOCO) Q4 results.
Will Cincinnati Financial (CINF) Top Estimates in Q4 Earnings?
by Zacks Equity Research
Cincinnati Financial's (CINF) Q4 results is likely to benefit from Better pricing, renewal price increases, higher level of insured exposure and disciplined expansion of Cincinnati Re.
What's in the Cards for Aon's (AON) Q4 Earnings Results?
by Zacks Equity Research
Aon's (AON) fourth-quarter results are likely to reflect a weak performance by its Commercial Risk Solutions, Data & Analytic Services, Health Solutions and Retirement Solutions segments.
What's in Store for Synchrony Financial (SYF) Q4 Earnings?
by Zacks Equity Research
Synchrony Financial (SYF) Q4 earnings results are likely to reflect COVID-led muted revenues.
AmEx's (AXP) Q4 Earnings Surpass Estimates, Decline Y/Y
by Zacks Equity Research
AmEx's (AXP) Q4 earnings gain traction from lower expenses and a solid performance by Global Consumer Services segment, offset by weak spending volumes.
Why Manulife (MFC) Could Beat Earnings Estimates Again
by Zacks Equity Research
Manulife (MFC) has an impressive earnings surprise history and currently possesses the right combination of the two key ingredients for a likely beat in its next quarterly report.
Here's Why Hold Strategy is Apt for Athene (ATH) Stock
by Zacks Equity Research
Athene (ATH) is well-poised to benefit from higher level of sales, growth in investment portfolio, higher bond call income and effective capital deployment.
CNO Financial (CNO) Up 48% in 6 Months: More Room to Run?
by Zacks Equity Research
CNO Financial (CNO) is set to grow on diversified product portfolio, integrated care platform and solid cash flows.